摘要
目的 :通过前哨淋巴活检技术证实乳腺癌的腋淋巴结转移是呈贯序性的 ,从而使腋淋巴结阴性的乳腺癌患者免行腋淋巴结清扫 ;方法 :以蓝染料作为前哨淋巴结的示踪剂 ,在肿瘤部位或肿瘤旁注射蓝染料 ,可直接在前哨淋巴结显示 ,从而发现乳腺癌的腋淋巴转移途径是呈贯序性的而非跳跃性的 ;结果 :以蓝染料作示踪剂发现前哨淋巴结的概率为 66%～ 98% ;结论 :前哨淋巴结活检 ,该项技术安全 ,易操作 ,损伤小 ,检测率高 ,经济 ,同时该项技术的出现证实了乳腺癌的腋淋巴结转移途径是呈贯序性的 ,从而使腋淋巴结阴性的乳腺癌患者免行腋淋巴结清扫 。
Objective:This study is to confirm that axillary lymphatic dissemination in breast cancer occurs sequentially by sentinel lymph node biospy so as to avoid unnecessary axillary lymph node dissection (ALND) in node-negative patients;Methods:Patent blue dye was injected into the tumor site or around the tumor as a tracer,which could be shown clearly in the sentinel lymph node.Thus sequential metastasis instead of skip metastasis was proved to occur in axillary lymphatic dissemination in breast cancer;Results:The accuracy rate of patent blue dye as a tracer to predict sentinel lymph node status was 66%～98%;Conclusion:This technique of sentinel lymph node biospy is safe,economical,highly predictive,minimally invasive and easy to operate.Moreover,it confirms that axillary lymphatic dissemination in breast cancer occurs sequentially so that ALND can be avoided in patents with clinically,negative lymph nodes.Therefore,this technique could be widely used in breast cancer surgeries.
出处
《内蒙古医学杂志》
2003年第3期222-223,共2页
Inner Mongolia Medical Journal
